NEWRON PHARMACEUT. EO-20 Cash Flow Reinvestment Rate
NEWRON PHARMACEUT. EO-20 cash flow reinvestment rate. NEWRON PHARMACEUT. EO-20 (NP5) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting €31.00K (capex €31.00K ) from operating cash flow of €33.60 Million. Explore NEWRON PHARMACEUT. EO-20 debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of NEWRON PHARMACEUT. EO-20 (2012–2025)
Cash flow reinvestment rate of NEWRON PHARMACEUT. EO-20 from 2012 to 2025. Historical reinvestment intensity for NEWRON PHARMACEUT. EO-20 across 2 annual periods. Explore NEWRON PHARMACEUT. EO-20 (NP5) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
NEWRON PHARMACEUT. EO-20 Cash Flow Reinvestment Rate by Year (2012–2025)
NEWRON PHARMACEUT. EO-20 cash flow reinvestment rate by year from 2012 to 2025. Year-by-year capital reinvestment analysis for NEWRON PHARMACEUT. EO-20. For the full cash flow conversion analysis, see NP5 cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.42x | €13.66 Million | €32.56 Million | €47.31K | ▲ +22119.7% |
| 2012 | 0.00x | €11.00K | €5.83 Million | €11.00K | — |